Abstract

PurposeRim lesions, characterised by a paramagnetic rim on susceptibility-based MRI, have been suggested to reflect chronic inflammatory demyelination in multiple sclerosis (MS) patients. Here, we assess, through susceptibility-weighted imaging (SWI), the prevalence, longitudinal volume evolution and clinical associations of rim lesions in subjects with early relapsing–remitting MS (RRMS).MethodsSubjects (n = 44) with recently diagnosed RRMS underwent 3 T MRI at baseline (M0) and 1 year (M12) as part of a multi-centre study. SWI was acquired at M12 using a 3D segmented gradient-echo echo-planar imaging sequence. Rim lesions identified on SWI were manually segmented on FLAIR images at both time points for volumetric analysis.ResultsTwelve subjects (27%) had at least one rim lesion at M12. A linear mixed-effects model, with ‘subject’ as a random factor, revealed mixed evidence for the difference in longitudinal volume change between rim lesions and non-rim lesions (p = 0.0350 and p = 0.0556 for subjects with and without rim lesions, respectively). All 25 rim lesions identified showed T1-weighted hypointense signal. Subjects with and without rim lesions did not differ significantly with respect to age, disease duration or clinical measures of disability (p > 0.05).ConclusionWe demonstrate that rim lesions are detectable in early-stage RRMS on 3 T MRI across multiple centres, although their relationship to lesion enlargement is equivocal in this small cohort. Identification of SWI rims was subjective. Agreed criteria for defining rim lesions and their further validation as a biomarker of chronic inflammation are required for translation of SWI into routine MS clinical practice.

Highlights

  • Multiple sclerosis (MS) is a chronic neurological condition affecting over 2 million individuals worldwide [1]

  • Motor and cognitive disability of participants are assessed via various measures including the Expanded Disability Status Scale (EDSS), the Timed 25-Foot Walk Test (T25FWT), the Paced Auditory Serial Addition Test (PASAT), the Symbol Digit Modalities Test (SDMT) and the Multiple Sclerosis Functional Composite (MSFC) score

  • Individual subject characteristics are provided in Supplementary Table S2

Read more

Summary

Introduction

Multiple sclerosis (MS) is a chronic neurological condition affecting over 2 million individuals worldwide [1]. MS is an immune-mediated disease characterised by inflammation, demyelination, neurodegeneration and remyelination. Inflammation drives activity during the relapsing–remitting stage, with neurodegeneration being predominant in progressive MS characterised by accumulating disability [2]. Whilst the reference standard for pathological characterisation is histological analysis of biopsy or, more commonly, autopsy material [3,4,5], recent progress in imaging raises the possibility of non-invasive and longitudinal measurement and ‘pathological’ characterisation of lesions. Susceptibility-based magnetic resonance imaging (MRI) provides support for the paramagnetic properties of certain MS lesions [6,7,8].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call